Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioblastoma × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 8 Lung Neoplasms 8 Breast Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Neoplasms 6 Brain Neoplasms 6 Thyroid Neoplasms 5 Prostatic Neoplasms 5 Colorectal Neoplasms 5 Colonic Neoplasms 5 Stomach Neoplasms 4 Thromboembolism 3 Myofibroma 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Uterine Neoplasms 2 Urinary Bladder Neoplasms 2 Supratentorial Neoplasms 2 Pain 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Leiomyoma 2 Hemangioma 2 Head and Neck Neoplasms 2 Depression 2 Arthritis, Rheumatoid 2 Agnosia 2 Vomiting 1 Visceral Pain 1 Uterine Cervical Neoplasms 1

Interventions

Temozolomide 186 Radiotherapy 109 Bevacizumab 84 Radiation 37 Irinotecan 26 Magnetic Resonance Spectroscopy 25 Carmustine 23 Surgical Procedures, Operative 21 Lomustine 19 Erlotinib Hydrochloride 18 Chemotherapy, Adjuvant 15 Carboplatin 15 sargramostim 11 Drug Therapy 11 temsirolimus 10 Radiosurgery 10 O(6)-benzylguanine 10 pembrolizumab 9 motexafin gadolinium 9 Vorinostat 9 Radiotherapy, Intensity-Modulated 9 Radiotherapy, Conformal 9 Imatinib Mesylate 9 Everolimus 9 Thalidomide 8 Sorafenib 8 Nivolumab 8 Gefitinib 8 cediranib 7 Sirolimus 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed

175 enrolled 18 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡